Early Pulmonary Effects of Excursion Deep Diving with Closed-circuit Gas Recycling: SPIDD Study

NCT ID: NCT05775562

Last Updated: 2024-12-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-19

Study Completion Date

2024-09-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Scuba diving with closed circuit gas rebreathers is currently booming. Initially developed for professional and military diving, this type of diving has become very successful in recreational activities.

The possibilities offered by this equipment are immense and reduce the constraints of exploration time and depth. More and more divers are seeking to reach depths previously considered unusual or inaccessible in recreational diving, beyond 100 meters. By pushing back these limits, the diver is exposed to new risks which should lead to a reflection on the means of prevention and treatment in case of incident.

The physiological repercussions of these deep dives are not well known. During daily deep excursions in the 90-120 meter zone, there is a significant reduction in vital capacity on leaving the dive, which persists and worsens the following day.

It seems necessary to confirm the importance of this impairment, never documented before, and to explore its mechanisms. A better knowledge of this respiratory impact could allow to improve the prevention and the preliminary evaluation of the medical aptitude of these divers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Physiopathology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diving arm

The standard arm involves all participants in the study. Subjects will perform pre-dive and post-dive examinations to characterize the respiratory impact of deep water diving

Group Type OTHER

Pre and post dive examinations

Intervention Type DIAGNOSTIC_TEST

Performing pre-dive examinations:

\- EFR by plethysmography cabin

Realization of the examinations the day of the dive:

* Portable Spirometry
* Pulmonary ultrasound
* Cardiac ultrasound
* Measurement of circulating bubbles
* ECG
* Venous blood sampling (biological collection)
* Water balance (Δweight/water intake)
* EFR by plethysmography cabin
* Weight measurement

Realization of the examinations the day after the dive:

* Venous blood sample (biological collection)
* Portable Spirometry
* Pulmonary ultrasound
* Cardiac ultrasound
* Weight measurement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pre and post dive examinations

Performing pre-dive examinations:

\- EFR by plethysmography cabin

Realization of the examinations the day of the dive:

* Portable Spirometry
* Pulmonary ultrasound
* Cardiac ultrasound
* Measurement of circulating bubbles
* ECG
* Venous blood sampling (biological collection)
* Water balance (Δweight/water intake)
* EFR by plethysmography cabin
* Weight measurement

Realization of the examinations the day after the dive:

* Venous blood sample (biological collection)
* Portable Spirometry
* Pulmonary ultrasound
* Cardiac ultrasound
* Weight measurement

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diver ≥ 18 years old
* Recreational rebreather diver with a recognised qualification (Mixed Gas CCR training or equivalent) and the necessary experience for this type of diving who has scheduled a dive in the 60 metre depth zone
* Diver using his/her own equipment, i.e. a closed circuit rebreather with back lungs meeting CE standards.
* Having a medical certificate of no contraindication to the practice of underwater activities \< 1 year issued by an authorised doctor
* Having taken out personal insurance covering this type of activity
* Voluntary and having given his/her express, free and informed consent
* Affiliated to the Social Security

Exclusion Criteria

* Diver refusal
* Known previous respiratory pathology
* Use of medication that may alter pulmonary and/or vascular function as well as inflammatory and haemostasis parameters
* Any temporary contraindication to the practice of scuba diving
* Patient under guardianship or trusteeship
* Immersion beyond 30 metres within 7 days or any scuba diving within the previous 48 hours.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Brest

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de BREST

Brest, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

29BRC21.0273

Identifier Type: -

Identifier Source: org_study_id